BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Lai YC, Yang JC, Huang SH. Pre-treatment urea breath test results predict the efficacy of Helicobacter pylori eradication therapy in patients with active duodenal ulcers. World J Gastroenterol 2004; 10(7): 991-994 [PMID: 15052680 DOI: 10.3748/wjg.v10.i7.991]
URL: https://www.wjgnet.com/1007-9327/full/v10/i7/991.htm
Number Citing Articles
1
Sergey I Pimanov, Elena V Makarenko, Alla V Voropaeva, Maya E Matveenko, Eugen V Voropaev. Helicobacter pylori eradication improves gastric histology and decreases serum gastrin, pepsinogen I and pepsinogen II levels in patients with duodenal ulcerJournal of Gastroenterology and Hepatology 2008; 23(11): 1666 doi: 10.1111/j.1440-1746.2007.04983.x
2
Masayuki Tatemichi, Shizuka Sasazuki, Manami Inoue, Shoichiro Tsugane. Clinical Significance of IgG Antibody Titer against Helicobacter pyloriHelicobacter 2009; 14(3): 231 doi: 10.1111/j.1523-5378.2009.00681.x
3
J.P. Gisbert, J.M. Pajares. 13C-urea breath test in the management of Helicobacter pylori infectionDigestive and Liver Disease 2005; 37(12): 899 doi: 10.1016/j.dld.2005.09.006
4
Javier P. Gisbert, Xavier Calvet, Anthony O'Connor, Francis Mégraud, Colm A. O'Morain. Sequential Therapy for Helicobacter pylori EradicationJournal of Clinical Gastroenterology 2010; 44(5): 313 doi: 10.1097/MCG.0b013e3181c8a1a3
5
Efrat Broide, Haim Shirin. Evaluation of Exalenz Bioscience’s BreathID forHelicobacter pyloridetectionExpert Review of Molecular Diagnostics 2015; 15(3): 299 doi: 10.1586/14737159.2015.982537
6
Bong-Ku Kang, Sung Min Park, Byung Wook Kim. New Therapeutic Strategies againstHelicobacter pyloriThe Korean Journal of Gastroenterology 2014; 63(3): 146 doi: 10.4166/kjg.2014.63.3.146
7
Jong Yeul Lee, Ji Yong Ahn, Il Ju Choi. Historical Perspective ofHelicobacter pyloriTreatment in KoreaThe Korean Journal of Helicobacter and Upper Gastrointestinal Research 2015; 15(4): 211 doi: 10.7704/kjhugr.2015.15.4.211
8
Muhammad Miftahussurur, Yoshio Yamaoka. Diagnostic Methods ofHelicobacter pyloriInfection for Epidemiological Studies: Critical Importance of Indirect Test ValidationBioMed Research International 2016; 2016: 1 doi: 10.1155/2016/4819423
9
Toshihiro Nishizawa, Hidekazu Suzuki, Masahiko Takahashi, Masayuki Suzuki, Toshifumi Hibi. Delay of second‐line eradication therapy for Helicobacter pylori can increase eradication failureJournal of Gastroenterology and Hepatology 2013; 28(10): 1608 doi: 10.1111/jgh.12281
10
Jyh-Chin Yang, Chun-Jung Lin. CYP2C19 genotypes in the pharmacokinetics/pharmacodynamics of proton pump inhibitor-based therapy ofHelicobacter pyloriinfectionExpert Opinion on Drug Metabolism & Toxicology 2010; 6(1): 29 doi: 10.1517/17425250903386251
11
Karen A. Krogfelt, Philippe Lehours, Francis Mégraud. Diagnosis of Helicobacter pylori InfectionHelicobacter 2005; 10(s1): 5 doi: 10.1111/j.1523-5378.2005.00341.x
12
Francis Mégraud, Philippe Lehours. Helicobacter pyloriDetection and Antimicrobial Susceptibility TestingClinical Microbiology Reviews 2007; 20(2): 280 doi: 10.1128/CMR.00033-06
13
Angelo Zullo, Carola Severi, Lucy Vannella, Cesare Hassan, Andrea Sbrozzi-Vanni, Bruno Annibale. Role of gastritis pattern on Helicobacter pylori eradicationInternal and Emergency Medicine 2012; 7(6): 517 doi: 10.1007/s11739-011-0730-4
14
Ju Yup Lee. Helicobacter pylori2023; : 541 doi: 10.1007/978-981-97-0013-4_44
15
Ki Bang Kim, Yong Sik Kim. Recent Trends ofHelicobacter pyloriEradication Therapy: Focusing on First Line TreatmentThe Korean Journal of Helicobacter and Upper Gastrointestinal Research 2014; 14(4): 237 doi: 10.7704/kjhugr.2014.14.4.237
16
Faezeh Kiani, Sara Khademolhosseini, Mobina Fathi, Arian Tavasol, Jasem Mohammadi, Majid Dousti, Jalal Eshagh Hoseini. Standard Triple Therapy as a Remedy for Treatment of Helicobacter pylori Infection: A Systematic Review and Meta-analysis of Randomized Clinical TrialsCurrent Reviews in Clinical and Experimental Pharmacology 2023; 18(2): 167 doi: 10.2174/2772432817666220317152544
17
György M. Buzás, Ilona Széles. Interpretation of the 13C-urea breath test in the choice of second- and third-line eradication of Helicobacter pylori infectionJournal of Gastroenterology 2008; 43(2): 108 doi: 10.1007/s00535-007-2135-8
18
Jung Won Lee. Helicobacter pylori2023; : 563 doi: 10.1007/978-981-97-0013-4_46
19
Olga P Nyssen, Adrian G McNicholl, Francis Megraud, Vincenzo Savarino, Giuseppina Oderda, Carlo Fallone, Lori Fischbach, Franco Bazzoli, Javier P Gisbert, Javier P Gisbert. Cochrane Database of Systematic Reviews2011;  doi: 10.1002/14651858.CD009034
20
V. De Francesco, A. Zullo, E. Ierardi, F. Giorgio, F. Perna, C. Hassan, S. Morini, C. Panella, D. Vaira. Phenotypic and genotypic Helicobacter pylori clarithromycin resistance and therapeutic outcome: benefits and limitsJournal of Antimicrobial Chemotherapy 2010; 65(2): 327 doi: 10.1093/jac/dkp445
21
Hyuk Yoon. Helicobacter pylori2016; : 447 doi: 10.1007/978-981-287-706-2_43
22
J.P. Gisbert, D. Olivares, I. Jimenez, J.M. Pajares. Is there any correlation between 13C-urea breath test values and response to first-line and rescue Helicobacter pylori eradication therapies?Digestive and Liver Disease 2006; 38(4): 254 doi: 10.1016/j.dld.2005.10.022
23
Olga P. Nyssen, Belén Martínez, Francis Mégraud, Vincenzo Savarino, Carlo A. Fallone, Franco Bazzoli, Javier P. Gisbert. Sequential versus Standard Triple Therapy for First-Line Helicobacter pylori Eradication: An UpdateAntibiotics 2024; 13(2): 136 doi: 10.3390/antibiotics13020136
24
J. P. Gisbert, X. Calvet. Review article: non-bismuth quadruple (concomitant) therapy for eradication of Helicobater pyloriAlimentary Pharmacology & Therapeutics 2011; 34(6): 604 doi: 10.1111/j.1365-2036.2011.04770.x
25
Ju Yup Lee. Helicobacter pylori2016; : 427 doi: 10.1007/978-981-287-706-2_41
26
Javier P Gisbert, Xavier Calvet, JP Anthony O'Connor, Francis Mégraud, Colm A O'Morain. The sequential therapy regimen forHelicobacter pylorieradicationExpert Opinion on Pharmacotherapy 2010; 11(6): 905 doi: 10.1517/14656561003657152
27
Olga P Nyssen, Adrian G McNicholl, Francis Megraud, Vincenzo Savarino, Giuseppina Oderda, Carlo A Fallone, Lori Fischbach, Franco Bazzoli, Javier P Gisbert. Sequential versus standard triple first-line therapy forHelicobacter pylorieradicationCochrane Database of Systematic Reviews 2016; 2016(6) doi: 10.1002/14651858.CD009034.pub2
28
Kee Don Choi. Current Trends ofHelicobacter pyloriEradication in KoreaThe Korean Journal of Helicobacter and Upper Gastrointestinal Research 2015; 15(3): 147 doi: 10.7704/kjhugr.2015.15.3.147
29
Su Young Kim, Dong Kyun Park, Kwang An Kwon, Kyoung Oh Kim, Yoon Jae Kim, Jun Won Chung. Ten Day Concomitant Therapy Is Superior to Ten Day Sequential Therapy forHelicobacter pyloriEradicationThe Korean Journal of Gastroenterology 2014; 64(5): 260 doi: 10.4166/kjg.2014.64.5.260
30
Y. S. Kim, S. J. Kim, J. H. Yoon, K. T. Suk, J. B. Kim, D. J. Kim, D. Y. Kim, H. J. Min, S. H. Park, W. G. Shin, K. H. Kim, H. Y. Kim, G. H. Baik. Randomised clinical trial: the efficacy of a 10-day sequential therapy vs. a 14-day standard proton pump inhibitor-based triple therapy for Helicobacter pylori in KoreaAlimentary Pharmacology & Therapeutics 2011; 34(9): 1098 doi: 10.1111/j.1365-2036.2011.04843.x
31
Angelo Zullo, Vincenzo De Francesco, Cesare Hassan. Predicting Helicobacter pylori EradicationJournal of Clinical Gastroenterology 2012; 46(4): 259 doi: 10.1097/MCG.0b013e318247177e
32
Jong In Kim, Byung-Wook Kim. Sequential Therapy ofHelicobacter pyloriInfectionThe Korean Journal of Helicobacter and Upper Gastrointestinal Research 2011; 11(2): 103 doi: 10.7704/kjhugr.2011.11.2.103
33
Angelo Zullo, Federico Perna, Chiara Ricci, Cesare Hassan, Andrea Tampieri, Vincenzo De Francesco, Sergio Morini, Dino Vaira. 13C-Urea Breath Test Values and Helicobacter pylori EradicationDigestive Diseases and Sciences 2008; 53(2): 370 doi: 10.1007/s10620-007-9893-2